UNSPSC 51281903: Nemorubicin

This classification denotes an anthracycline antibiotic with the molecular formula C32H37NO13, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7618O47BQM, chemically known as 5,12-naphthacenedione, 7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-10-((2,3,6-trideoxy-3-(2-methoxy-4-morpholinyl)-alpha-l-lyxo-hexopyranosyl)oxy)-, (8s-cis)- but generally known as nemorubicin, which bears US NIH Compound Identifier 65907.

UNSPSC 51281903 Nemorubicin is a Commodity code covering a specific chemotherapy agent used in cancer treatment protocols. State and local governments procure this pharmaceutical through health departments, public health systems, cancer centers, and correctional-facility medical units that operate oncology programs or serve inmate populations requiring chemotherapy. The drug is typically sourced through competitive pharmaceutical bidding processes, group purchasing agreements, or state formulary programs that negotiate pricing with manufacturers and authorized distributors.

The source provides no recent state or local contract opportunities under this code. Without posted solicitations or awarded contracts in the available record, the current procurement activity and geographic concentration cannot be characterized. Potential buyers should monitor health department RFQs, state pharmaceutical cooperative-purchasing vehicle announcements, and public hospital system procurement notices, particularly in states with large correctional or safety-net health systems, though this code shows no visible recent activity in the sourced data.